Cobrotoxin could be an effective therapeutic for COVID-19

Saved in:
Bibliographic Details
Published in:Acta pharmacologica Sinica 2020-09, Vol.41 (9), p.1258-1260
Main Authors: Lin, Fang, Reid, Paul F., Qin, Zheng-hong
Format: Article
Language:English
Subjects:
Betacoronavirus - drug effects
Betacoronavirus - metabolism
Biomedical and Life Sciences
Biomedicine
Blood Coagulation - drug effects
Cobra Neurotoxin Proteins - pharmacology
Coronavirus Infections - blood
Coronavirus Infections - drug therapy
Coronavirus Infections - immunology
Coronaviruses
Correspondence
COVID-19
Humans
Immunity, Cellular - drug effects
Immunology
Inflammation - drug therapy
Internal Medicine
Kinases
Lymphocytes
Medical Microbiology
Neurotoxins - pharmacology
Pandemics
Pharmacology/Toxicology
Pneumonia, Viral - blood
Pneumonia, Viral - drug therapy
Pneumonia, Viral - immunology
Pulmonary Fibrosis - prevention & control
Pulmonary Fibrosis - virology
SARS-CoV-2
Treatment Outcome
Vaccine
Viral infections
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:1671-4083
1745-7254
DOI:10.1038/s41401-020-00501-7